期刊文献+

DC-CIK治疗恶性肿瘤58例的护理体会 被引量:2

58 cases of malignant tumor therapy treated with DC-CIK
下载PDF
导出
摘要 目的总结DC-CIK治疗的护理要点,为患者提供有效、安全的治疗和护理。方法通过对58例行DC-CIK治疗的恶性肿瘤患者进行回顾性总结、分析,从采集细胞、输注治疗两大环节,总结该项治疗的流程和观察护理要点。结果行DC-CIK治疗的58例患者在接受规范化、流程化的采集和输注护理后,均取得有效的护理和积极的治疗效果。结论规范的操作,细致的观察,全面的宣教是保证DC-CIK治疗成功的关键。 Objective To summarize nursing highlights with DC-CIK treatment so as to provide patients with effective and safe treatment and nursing.Methods Based on retrospective summary and analysis of 58 patients with routine DC-CIK treatment on malignant tumor,the treatment process and nursing points were summarized in terms cell collection and infusion.Results Fifty-eight patients who received treatment of DC-CIK after normative and routine collection and infusion,have achieved positive therapeutic and valid nursing effects.Conclusion Standard operation,meticulous observation and comprehensive education are key to ensure successful DC-CIK treatment.
作者 李素平
出处 《实用临床医药杂志》 CAS 2011年第16期7-8,共2页 Journal of Clinical Medicine in Practice
关键词 树突状细胞-细胞因子诱导的杀伤细胞 免疫治疗 恶性肿瘤 护理 dendritic cells-cell factors inducing the killer cells immune therapy malignant tumor nursing
  • 相关文献

参考文献5

二级参考文献29

  • 1范爱飞,郭辉,匡剑英,伊华.治疗性血液成分单采术患者的护理[J].南方护理学报,2004,11(7):35-36. 被引量:5
  • 2郭宗娥,王明琳.血细胞单采术辅助治疗白血病和真性红细胞增多症[J].中国输血杂志,2004,17(4):264-265. 被引量:5
  • 3夏穗生 黄光英 张良华.肿瘤临床诊疗指南[M].北京:科技出版社,1999.368.
  • 4Hoffmant DM, Citlitz B, Belldegrun A, et al. Adoptive celluar therapy [J]. Semin Oncol, 2000,27(2): 221-233.
  • 5Wolf Schmidt-wolf GD, Negrin RS, Wolf Schmidt-wolf IGH, Activated T cells and cytokine-induced CD3^+CD56^+ killer cells [J]. Ann Heamalol, 1997,74(2) : 51-56.
  • 6Bancher J, Steinman RM. Dendritic cells and the control of immunity[J]. Nature, 1998,392(66):245-52.
  • 7Marten A, Ziske C, Schottker B, et al. Interactions between dendritic cells and cytokine-induced killer cells lead to an activation If both populations [J]. J Immunotherapy,2001,24:502-510.
  • 8Wolf SIGH, Negrin RS, Kiem HP, et al. Use of a SCID Mouse/Human lymphoma model to evaluate cytokineinduced killer cells with potent antitumor cell activity [J].J Exp Med, 1991,174: 139-145.
  • 9LU PH, Negrin RS. A novel population of expanded human CD3^+CD56^+ cell derived from T cells with potent in vivo antitumor activity in mice with severe combined immunodeficiency[J]. J Immunol, 1997,153:1687-1693.
  • 10Marten A,Ziske C,Schottker B,et al. Interactions between dendritic cells and cytotkine-Induced killer cells lead to an activation of both populations [J]. J Immuno l,2001,24(6):502.

共引文献27

同被引文献31

引证文献2

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部